Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History PULM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics PULM

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Pulmatrix Inc

PULM
Current price
6.51 USD -0.05 USD (-0.76%)
Last closed 6.56 USD
ISIN US74584P3010
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 23 849 390 USD
Yield for 12 month +214.49 %
1Y
3Y
5Y
10Y
15Y
PULM
21.11.2021 - 28.11.2021

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts. Address: 945 Concord Street, Framingham, MA, United States, 01701

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.00 USD

P/E Ratio

Dividend Yield

Financials PULM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures PULM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+7 806 000 USD

Last Year

+7 298 000 USD

Current Quarter

Last Quarter

+3 000 USD

Current Year

+7 806 000 USD

Last Year

-8 220 000 USD

Current Quarter

Last Quarter

+3 000 USD
EBITDA -9 665 500 USD
Operating Margin TTM -506.98 %
Price to Earnings
Return On Assets TTM -31.67 %
PEG Ratio
Return On Equity TTM -93.19 %
Wall Street Target Price 10.00 USD
Revenue TTM 1 921 000 USD
Book Value 1.96 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -99.90 %
Dividend Yield
Gross Profit TTM 1 888 000 USD
Earnings per share -3.35 USD
Diluted Eps TTM -3.35 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation PULM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 7.46
Price Sales TTM 12.42
Enterprise Value EBITDA 1.57
Price Book MRQ 3.34

Technical Indicators PULM

For 52 Weeks

1.78 USD 10.40 USD
50 Day MA 7.21 USD
Shares Short Prior Month 21 919
200 Day MA 5.88 USD
Short Ratio 1.25
Shares Short 30 712
Short Percent 0.85 %